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Abstract
Background: Few studies have considered source-specific micronutrient intake in relation to mortality under
the consideration that dietary and supplemental intake could exhibit different effects.
Objective: To evaluate the association between intake of vitamin C, E, folate, beta-carotene from diet and
supplements, and overall mortality. Furthermore, to examine effect modification by smoking, alcohol intake,
and BMI and to investigate if the effect of supplement use differs with dietary micronutrient intake.
Methods and Material: In a prospective cohort study of 55,453 middle-aged Danes, information regarding
diet, supplement use, and lifestyle was collected through questionnaires. During follow-up, 6,767 deaths were
identified and incidence rate ratios (IRRs) of mortality related to micronutrient intake were calculated using
Cox proportional hazards models.
Results: The present study found no effect of dietary vitamin C, E, folate, or beta-carotene in relation to
mortality. In contrast, supplemental folic acid was associated with a significantly increased mortality, whereas
no other micronutrient supplement was associated with mortality. Effect modification by smoking and
alcohol intake, but not BMI, was suggested in relation to some dietary micronutrients. The effect of
supplements did not differ in groups defined by dietary micronutrient intake.
Conclusion: This study suggests no effect of dietary micronutrients in relation to overall mortality.
Supplemental folic acid was found to be associated with increased mortality, but further studies are required.
No other supplemental micronutrient was associated with mortality.
Keywords: mortality; dietary supplements; micronutrients; prospective cohort study; vitamin C; vitamin E; folate;
beta-carotene
O
xidative stress has been suggested to play a role in
the development of cancer (1, 2) as well as
cardiovascular disease (3), the two leading causes
of death in industrialised countries. On the basis of this, it
has been proposed that antioxidants might decrease the
risk of these diseases and hereby overall mortality.
Antioxidants and other micronutrients are frequent in
the diet, especially in fruit and vegetables, but are also
commonly consumed through supplements. Whereas
some studies report that dietary micronutrient intake is
associated with beneficial effects in relation to cancer (4)
and cardiovascular disease (5, 6), studies on supplemental
micronutrients have fairly consistently shown no bene-
ficial effects, and some studies have even suggested
harmful effects of micronutrient supplements in relation
to mortality (7, 8) and to specific cancer and cardiovas-
cular disease outcomes (913).
In Denmark, use of micronutrient supplements is
widespread with more than 50% of the population using
supplements regularly (14). This is the highest frequency
of use in Europe (14, 15), but use is generally common in
the northern parts of Europe (14) and in the United
States (16). For some micronutrients, a supplement
becomes the primary source of the micronutrient among
users (17), as supplemental micronutrients are often more
bioavailable than their natural counterparts (1720).
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ent effects when consumed through the diet compared to
when consumed in a supplement due to differences in
dose (18, 21, 22), but also that the micronutrient source in
itself may render different effects of the same micronu-
trient due to different biological properties (23, 24)
and synergistic interactions of dietary micronutrients
and other parts of the food matrix, which cannot be
replicated in supplements (2527). Few studies have
specifically considered source-specific effects of micronu-
trients in relation to mortality under the consideration
that these could differ.
On the basis of this, the aim of the present study was to
evaluate the association between intake of dietary and
supplemental vitamin C, vitamin E, folate, beta-carotene,
and overall mortality. Furthermore, we examined effect
modification by smoking, alcohol intake, BMI, and if the




The prospective Diet, Cancer and Health study invited
160,725 Danes to participate from 1993 to 1997. Inclu-
sion criteria were 5064 years of age, residence in the
greater Copenhagen or Aarhus area, and no previous
cancer diagnosis in the Danish Cancer Registry; 57,053
participants accepted the invitation (28). The study was
approved by the regional ethical committees of human
studies in Copenhagen and Aarhus and by the Danish
Data Protection Agency.
Diet and risk factor assessment
Diet was assessed at baseline through a 192-item food
frequency questionnaire (29) considering food intake and
supplement use during the past 12 months. Description
of the development and validation of the questionnaire
has been published previously (2932). Average intake of
each food item during the last 12 months was reported in
12 possible categories from ‘never’ to ‘eight times or more
per day.’ Participants also provided information on
supplement use through open-ended questions on brands
and doses and categorical questions on consumption
frequency; that is, how many months during the last year
they had consumed the supplements and how many
tablets they had consumed per day in the given period.
Information on micronutrient content in each supple-
ment brand was obtained from producers or distributors.
For each participant, average daily micronutrient intake
was calculated by the software programme Food Calc
(33) as total, dietary, and supplemental intake. Further-
more, each participant filled in a lifestyle questionnaire
including information on factors relevant for mortality.
Exclusion criteria
Participants were excluded if they lacked information
concerning micronutrient intake or covariates (n 
1,600). In total, 26,609 men and 28,844 women were
included in the analyses.
Follow-up and case ascertainment
Information on vital status and emigration of partici-
pants was obtained from the Central Population Registry.
Follow-up was initiated on the day of the visit to the
study clinic and continued until date of death, date of
emigration, or March 30, 2010  whichever came first.
Statistical analysis
The analyses between exposure variables and mortality
were based on Cox proportional hazards models with
follow-up time as the underlying time scale. We stratified
for age in 1-year intervals; that is, allowing for different
shapes of the hazard function in the different age
intervals (34).
Estimates were calculated as crude estimates and as
adjusted estimates. All adjusted models were adjusted for
alcohol intake (g/day), Body Mass Index (BMI) (kg/m
2),
waist circumference (cm), smoking status (never, former,
current), smoking duration (years), smoking intensity (g/
day), time since cessation (years), educational status (B7,
710,  10 years), physical activity (sport [yes/no] and
cycling [yes/no]). Supplemental and dietary intake was
always mutually adjusted and when considering one
micronutrient, the analyses were adjusted for the three
others.
Quantitative variables were included linearly in the Cox
model as this increases the power of the analysis (35).
Linearity was evaluated graphically using linear spline
models with boundaries at the three quartiles among
cases (36). Both BMI and alcohol intake were found to be
related to mortality in a U-shaped association and were
therefore each entered into the models as linear splines
with boundaries placed at BMI: 25 kg/m
2 and alcohol
intake: 10 g/day for both sexes. No other variables
showed deviation from linearity, and these were therefore
included linearly into the model.
Incidence rate ratios (IRRs) of the association with
linear micronutrient variables were presented as IRRs
associated with a 100 mg/day higher consumption for
vitamin C, 10 mg/day for vitamin E, 100 mg/day for folate,
and 5,000 mg/day for beta-carotene. These units were
based on evaluations of the interquartile range of the
different linear micronutrient variables among cases.
All tests were based on the likelihood ratio test statistic.
Two-sided 95% confidence intervals were calculated
based on Wald’s test of the Cox regression parameter,
i.e. on the log ratio scale. The SAS procedure PHREG in
SAS 8.2 on the TextPad platform was used for statistical
analyses.
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A total of 6,767 deaths occurred during a median follow-
up of 13.8 years (595% percentile: 7.615.4). The
characteristics of the study population are summarised
in Table 1. As expected, cases were older at baseline and a
higher number were males, current smokers, had a lower
education, and a higher daily alcohol intake (Table 1).
Table 2 shows the relationship between micronutrient
intake and mortality. We found a significantly increased
mortality risk with supplemental folic acid (IRR: 1.02,
95% CI: 1.011.03) but not with dietary folate (IRR: 1.02,
95% CI: 0.981.05). When considering total folate, the
association was also significant (IRR: 1.02, 95% CI: 1.01
1.03). No other micronutrient was associated with
mortality regardless of source: diet, supplement, or total
intake (results not shown).
To consider possible effect modification by lifestyle,
analyses were conducted stratified by smoking status
Table 1. Baseline characteristics of cases and study-population by selected demographic and established risk factors and intake of
micronutrients
Cases (n  6,767) Cohort (n  55,453)
Median 595% percentile N (%) Median 595% N (%)
Age at baseline 59.0 51.064.0 56.0 50.064.0
Sex
Male 4073 (60.2) 26609 (48.0)
Female 2694 (39.8) 28844 (52.0)
Smoking status
Never 1223 (18.1) 19573 (35.3)
Former 1630 (24.1) 15733 (28.4)
Current 3914 (57.8) 20147 (36.3)
BMI (kg/m
2) 26.0 19.934.9 25.6 20.533.4
Education
B 7 years 2886 (42.7) 18365 (33.1)
7  10 years 2807 (41.5) 25513 (46.0)
  10 years 1074 (15.9) 11575 (20.9)
Alcohol intake (g/day)
4 15.7 1.089.2 13.4 1.165.1
Sport 2589 (38.3) 29653 (53.5)
Cycling 3949 (58.4) 37428 (67.5)
Vitamin C (mg/day)
Dietary intake 91.8 38.0213.6 97.8 44.1210.2
Supplemental intake
5 60.0 7.1666.0 60.0 7.1590.0
Percentage using supplements 3193 (47.2) 28563 (51.5)
Folate (mg/day)
Dietary intake 318.8 178.7542.3 325.2 189.4521.8
Supplemental intake
5 100.0 16.7300.0 100.0 11.9283.2
Percentage using supplements 2620 (38.7) 23418 (42.2)
Vitamin E (mg/day)
Dietary intake 8.3 4.414.8 8.6 4.714.3
Supplemental intake
5 10.0 1.472.0 10.0 1.275.0
Percentage using supplements 3001 (44.1) 27417 (49.4)
Beta-carotene (mg/day)
Dietary intake 2480.9 603.111769.8 3205.4 795.913016.3
Supplemental intake
5 2254.5 187.215300.0 2254.5 187.216002.5
Percentage using supplements 120 (1.8) 1435 (2.6)
1 Among ever smokers.
2 Among current smokers.
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g/day,  10 g/day) and BMI (525, 25). There was a
significant interaction between dietary folate and smok-
ing status with an increased mortality risk among never
smokers (IRR: 1.12, 95% CI: 1.051.19) but not among
former and current smokers. Also, the effect of dietary
vitamin E was significantly modified by smoking status
with a similar increased risk of mortality (IRR: 1.27, 95%
CI: 1.041.55) among never smokers but not among
former and current smokers. Among current smokers, in
fact, a significantly decreased risk was found (IRR: 0.79,
95% CI: 0.690.91) (Table 3). When considering effect
modification by alcohol intake, dietary vitamin E was
associated with significantly decreased risk of death
among those consuming above 10 g alcohol/day (IRR:
0.76, 95% CI: 0.660.87) but not among those consuming
less or no alcohol (Table 4). No significant interactions
were found between micronutrient intake and BMI
(results not shown).
We also evaluated effect modification by intake from
opposite sources. Supplemental intake was categorised
by dietary intake: two equally sized groups consuming
below the recommended daily intake (RDI) and two
equally sized groups consuming above the RDI for
vitamins C, E, and folate. For beta-carotene no cate-
gorisation on diet was conducted, as supplement use was
very limited and could therefore not be considered in
multiple groups. No beneficial effects of supplement
consumption were seen, regardless of the dietary intake
of the micronutrient in question. Furthermore, we
evaluated if the effect of dietary micronutrients differed
among users and non-users of the corresponding supple-
ment. No significant differences were found (results not
shown).
Table 2. Incidence rate ratios (IRR) for all-cause mortality associated with intake of vitamin C, folate, vitamin E, and beta-carotene
Continuous analyses Categorical analyses
2
Crude IRR









Dietary intake 0.85 (0.810.90) 1.05 (0.991.11) 1.0 (ref.) 0.88 (0.820.94) 0.87 (0.800.93) 0.97 (0.891.06) 0.08
Supplemental
intake
1.00 (0.991.00) 1.00 (0.991.01) 1.0 (ref.) 0.97 (0.881.07) 1.06 (0.951.18) 1.02 (0.931.12) 0.51
Folate
4
Dietary intake 0.94 (0.910.96) 1.02 (0.981.05) 1.0 (ref.) 0.88 (0.820.95) 0.87 (0.810.94) 0.93 (0.851.03) 0.38
Supplemental
intake
1.00 (0.991.02) 1.02 (1.01-1.03) 1.0 (ref.) 1.06 (0.961.16) 1.13 (1.021.24) 1.04 (0.941.16) 0.0025
Vitamin E
5
Dietary intake 0.76 (0.700.82) 0.90 (0.801.02) 1.0 (ref.) 0.85 (0.800.92) 0.81 (0.750.88) 0.85 (0.780.94) 0.10
Supplemental
intake
0.99 (0.991.00) 1.00 (1.001.01) 1.0 (ref.) 0.83 (0.750.92) 0.89 (0.800.99) 0.88 (0.790.98) 0.70
Beta-carotene
6
Dietary intake 0.86 (0.830.89) 0.98 (0.951.01) 1.0 (ref.) 0.86 (0.800.92) 0.81 (0.750.87) 0.79 (0.730.86) 0.29
Supplemental
intake
0.91 (0.821.01) 1.02 (0.911.15) 1.0 (ref.) 0.80 (0.581.09) 0.92 (0.681.26) 0.87 (0.631.19) 0.78
1 Per 100 mg increment/day for vitamin C, 100 mg increment/day for folate/folic acid, 10 mg increment/day for vitamin E, and 5,000 mg increment/day for
beta-carotene.
2 Adjusted for total intake of the three other micronutrients as well as dietary intake for the supplemental intake and supplemental intake for the dietary
intake and further for alcohol intake, BMI, waist circumference, smoking status (never/former/present), smoking duration, smoking intensity, time since
cessation, education, and physical activity (sport yes/no and cycling yes/no).
3 Cut points for dietary vitamin C: 565.19 mg; 591.77 mg; 5127.75 mg; cut points for supplemental vitamin C: 0 mg;  0m g539.96 mg; 560.00
mg.
4 Cut points for dietary folate: 5254.96 mg; 5318.77 mg; 5 395.80 mg; cut points for supplemental folate: 0 mg;  0 mg 583.2 mg; 5150.0 mg.
5 Cut points for dietary vitamin E: 56.51 mg; 58.36 mg; 510.60 mg; cut points for supplemental vitamin E: 0 mg;  0m g56.66 mg; 510 mg.
6 Cut points for dietary beta-carotene: 51317.07 mg; 52480.90 mg; 54797.69 mg; cut points for supplemental beta-carotene: 0 mg;  051250.00 mg;
55994.00 mg.
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Never Smokers (1,223 cases / 18,350
non-cases)
Former smokers (1,630 cases/14,103
non-cases)
Current Smokers (3,914 cases/16,233
non-cases)
Crude IRR
1 95% CI Adjusted IRR
1,.2 95% CI Crude IRR
1 95% CI Adjusted IRR
1,.2 95% CI Crude IRR




Vitamin C 1.03 (0.931.14) 1.11 (1.001.24) 0.96 (0.871.05) 1.06 (0.961.17) 0.90 (0.850.96) 1.03 (0.961.10) 0.37
Dietary intake
Supplemental intake 1.01 (0.981.04) 1.01 (0.981.03) 0.99 (0.971.01) 0.99 (0.971.02) 1.00 (0.991.02) 1.01 (0.991.02) 0.54
Folate
Dietary intake 1.05 (0.991.11) 1.12 (1.051.19) 0.97 (0.921.01) 1.03 (0.971.09) 0.95 (0.920.98) 0.99 (0.951.03) 0.0005
Supplemental intake 1.02 (1.011.04) 1.02 (1.011.03) 1.01 (0.991.03) 1.01 (0.991.03) 1.02 (0.991.05) 1.01 (0.981.04) 0.69
Vitamin E
Dietary intake 1.21 (1.011.45) 1.27 (1.041.55) 0.91 (0.771.07) 0.98 (0.811.18) 0.72 (0.650.80) 0.79 (0.690.91) B.0001
Supplemental intake 1.00 (0.991.01) 1.00 (0.991.01) 1.01 (1.001.01) 1.01 (1.001.02) 1.00 (0.991.01) 1.00 (0.991.01) 0.26
Beta-carotene
Dietary intake 0.95 (0.901.01) 0.97 (0.921.03) 0.97 (0.921.02) 1.01 (0.961.06) 0.88 (0.840.92) 0.97 (0.931.01) 0.36
Supplemental intake 1.08 (0.891.31) 1.04 (0.851.27) 1.06 (0.891.26) 1.05 (0.891.25) 0.98 (0.821.18) 0.97 (0.811.16) 0.77
Note: Stratified by smoking status.
1 Per each additional 100 mg vitamin C, 100 mg folate, 10 mg vitamin E, or 5,000 mg beta-carotene.
2 Adjusted for total intake of the three other micronutrients as well as dietary intake for the supplemental intake and supplemental intake for the dietary intake and further for alcohol intake, BMI, waist


































































































































)Table 4. Incidence rate ratio for mortality, associated with intake of vitamin C, folate, vitamin E, and beta-carotene
Abstainers (314 cases/974 non-cases)  0510 g/day (2,231 cases/18,040 non-cases)   10 g/day (4,222 cases /29,672 non-cases)
Crude IRR
1 95% CI Adjusted IRR
1,.2 95% CI Crude IRR
1 95% CI Adjusted IRR
1,.2 95% CI Crude IRR
1 95% CI Adjusted IRR
1,.2 95% CI P-value from adjusted analyses
Vitamin C
Dietary intake 0.96 (0.821.13) 1.04 (0.891.22) 0.91 (0.840.98) 1.09 (1.01.001.18) 0.81 (0.760.86) 1.00 (0.941.08) 0.24
Supplemental intake 1.02 (0.981.06) 1.03 (0.991.07) 1.02 (1.011.03) 1.01 (1.001.03) 1.00 (0.991.02) 0.99 (0.981.01) 0.07
Folate
Dietary intake 0.99 (0.901.08) 1.05 (0.961.15) 0.93 (0.900.97) 1.07 (1.011.12) 0.93 (0.910.96) 1.04 (1.001.08) 0.60
Supplemental intake 1.08 (0.971.19) 1.08 (0.971.20) 1.04 (1.021.05) 1.03 (1.021.05) 1.00 (0.981.02) 1.00 (0.981.03) 0.07
Vitamin E
Dietary intake 1.05 (0.791.41) 0.97 (0.711.31) 0.89 (0.781.03) 0.93 (0.791.10) 0.67 (0.600.74) 0.76 (0.660.87) 0.0325
Supplemental intake 0.99 (0.961.02) 1.00 (0.971.02) 1.01 (1.001.01) 1.01 (1.001.02) 1.00 (0.991.00) 1.00 (0.991.00) 0.05
Beta-carotene
Dietary intake 0.79 (0.690.90) 0.90 (0.791.02) 0.89 (0.850.93) 0.98 (0.941.03) 0.85 (0.810.89) 0.98 (0.941.02) 0.39
Supplemental intake 0.85 (0.471.55) 0.96 (0.551.68) 1.02 (0.861.21) 1.01 (0.851.22) 1.05 (0.911.21) 1.03 (0.891.19) 0.97
Note: Stratified by alcohol intake.
1 Per each additional 100 mg vitamin C, 100 mg folate, 10 mg vitamin E, or 5,000 mg beta-carotene.
2 Adjusted for total intake of the three other micronutrients as well as dietary intake for the supplemental intake and supplemental intake for the dietary intake and further for BMI, waist circumference,

























































































































In this prospective Danish cohort study, supplemental
folic acid was associated with an increased risk of death.
None of the dietary micronutrients investigated were
associated with overall mortality and neither was any
other supplemental micronutrient. Effect modification
was found for smoking and dietary folate, and vitamin E,
and for alcohol and dietary vitamin E, whereas no effect
modification by BMI was found.
The strengths of the present study include a long
follow-up time, allowing accumulation of a large number
of cases. The prospective design eliminated the risk of
recall bias. We had complete and valid identification of
all deaths and comprehensive information on dietary and
supplemental micronutrients. This made precise calcula-
tions of micronutrient intake with source possible,
enabling us to mutually adjust dietary and supplemental
consumption of each micronutrient. Comprehensive in-
formation was also available on potential confounders.
The estimation of dietary micronutrient intake may be
imprecise due to the variation in micronutrient content in
different foods, varying with climate, growth, and storage.
Also, use of baseline micronutrient consumption as a
proxy for consumption during the entire study period
may not be accurate, especially so for supplement use.
However, possible bias from these factors is expected to
be non-differential and should lead to bias towards the
null, if any.
This study was conducted in a population with a
relatively high dietary micronutrient intake (Table 1).
Dietary intake of vitamin C and folate in the cohort is
above the RDI (37) for both sexes and vitamin E also for
women. For beta-carotene no RDI exists. This suggests a
population that is by no means deprived in micronutrient
status. For poorly nourished populations, previous stu-
dies have suggested beneficial effects of micronutrient
supplements in relation to mortality (3840), whereas
randomised, controlled trials (RCTs) on micronutrient
supplements and overall mortality in well-nourished
adult populations have consistently not shown any effects
of supplementation on risk of death (4146), or even
increased risk (7, 8), in line with our finding of no
beneficial effects of adding micronutrient supplements to
the diet.
In contrast, we found a significantly increased risk of
death with supplemental folic acid. Folic acid from
supplements have, in RCTs, been associated with an
increased risk of colorectal adenomas (12), prostate
cancer (11), lung cancer and mortality (47), and evidence
is accumulating that folate may play a dual role in
carcinogenesis with harmful effects among persons har-
bouring pre-neoplastic lesions (48). No general tendency
towards beneficial or harmful effects of folic acid
supplementation has been found in RCTs on cardiovas-
cular disease (13, 4446, 49). However, the detrimental
effect of supplemental folic acid could be explained by an
increased cancer risk alone. In previous studies examining
supplemental folic acid in relation to lung, colorectal,
breast, and bladder cancer in the Diet, Cancer and
Health cohort, we have, however, not found increased
incidence of these (5053). And when considering cause-
specific mortality in this study, information that was
available for participants deceased up until December
31, 2008, we found no association with cancer (IRR: 1.01;
95% CI: 0.991.04) or cardiovascular disease (IRR: 0.96;
95% CI: 0.861.07), but an increased risk of endocrine,
nutritional, and metabolic disorders (IRR: 1.05; 95% CI:
1.031.07), diseases of the respiratory system (IRR: 1.04;
95% CI: 1.011.07), and diseases of the digestive system:
(IRR: 1.04; 95% CI: 1.011.06). The primary source of
supplemental folic acid in the Diet, Cancer and Health
cohort is multivitamins, followed by vitamin B com-
plexes, or single folic acid supplements, but we did not
have comprehensive information regarding folic acid
source, allowing consideration of different effects of the
diverse supplements. Other vitamin Bs associated with
folic acid in vitamin B complexes may therefore be the
true active ingredient. Control for intake of vitamin B1,
B2,B 3,B 6, and B12 did however not materially alter the
estimate (IRR: 1.02; 95% CI: 1.001.03), suggesting that
these could not fully explain the harmful effect.
With regards to effect modification by lifestyle factors,
dietary vitamin E was associated with a decreased
mortality among current smokers and those with an
alcohol intake above 10 g/day (Table 3 and 4), and dietary
folate was associated with an increased mortality among
never smokers only (Table 3). These findings could be due
to limited statistical power in the sub-groups defined by
never/former smoking or abstinence/low alcohol intake,
as a number of cases in these groups is substantially
lower. Apart from the group of abstainers, however, the
number of cases should be high enough to show an
association if one was present. It is, therefore, also
possible that these findings are the result of multiple
testing or that they are caused by current smokers who
neglect to inform about their true smoking status, leading
to differential misclassification of these participants. And
as smokers will often also have a lower dietary micro-
nutrient intake (54, 55), this will skew the association
towards being harmful among never smokers and bene-
ficial among smokers. We would, however, then expect to
see a similar effect modification by vitamin C and beta-
carotene. Smoking and alcohol are also known to lower
the bioavailability of micronutrients (56, 57) and if these
do indeed have harmful effects in relation to mortality, it
is possible that these are cushioned by current smoking or
a high alcohol intake. Another explanation for the
findings could also be that only current smokers and
those with a high alcohol intake have an additional
benefit of a healthy diet. A similar effect of vitamin C and
Micronutrients and mortality
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studies examining effect modification by these factors are
required.
The results of this study suggest that supplements
containing the four included micronutrients have no
effect in relation to overall mortality in a population of
well-nourished Danes. In contrast, the only overall effect
seems to be a harmful effect of supplemental folate. This
finding, however, needs further scrutinising, as it does not
seem to be a strong and consistent finding across
different strata in the study where conflicting results are
seen.
In conclusion, the results of this prospective observa-
tional study in a cohort of middle-aged Danes indicate no
beneficial effect of dietary micronutrient intake in rela-
tion to mortality, suggesting that if these play a role in
health and survival, it may be minor and related to
specific outcomes, not generating an effect that can be
seen in relation to overall mortality in a generally well-
nourished population. A significantly increased risk of
death with supplemental folic acid was found, which is in
line with studies finding increased cancer incidence of
folic acid supplementation. Finally, effect modification by
smoking and alcohol was suggested and needs further
exploration.
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